Clinical Trials List
2025-06-15 - 2028-03-31
Phase I/II
Recruiting3
ICD-10C33
Malignant neoplasm of trachea
ICD-10Z51.12
Encounter for antineoplastic immunotherapy
ICD-9162.0
Malignant neoplasm of trachea
-
-
Trial Applicant
Pharmaceutical Research Associates Taiwan Inc.
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/09
Investigators and Locations
Co-Principal Investigator
- JIN-YUAN SHIH 無
- Chia-Chi Lin 無
- 廖斌志 無
- YEN-TING LIN 無
- 吳尚俊 無
- WEI-LI MA 無
- 黃信端 無
- 黃得瑞 無
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- WEI-LI MA Division of Hematology & Oncology
- 陳冠宇 Division of Hematology & Oncology
- 楊景堯 Division of Hematology & Oncology
- Jih-Hsiang Lee Division of Hematology & Oncology
- 徐偉勛
- JIN-YUAN SHIH
- CHAO-CHI HO CHAO-CHI HO
- 許嘉林
- 蔡子修
- YEN-TING LIN
- Chong-Jen Yu
- 廖斌志
- 廖唯昱
- 吳尚俊
- Chia-Chi Lin
- 黃信端
- 黃得瑞
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
Exclusion Criteria
The Estimated Number of Participants
-
Taiwan
50 participants
-
Global
420 participants
